Top Markets
#1 MowCat MowCat +49.06%
#2 Fake World Assets Fake World Assets +30.30%
#3 Velvet Velvet +25.87%
#4 Bitway Bitway +25.63%
#5 aPriori aPriori +21.25%
#6 OVERTAKE OVERTAKE +20.98%
#7 Derive Derive +15.93%
#8 Verus Coin Verus Coin +15.91%
#9 Biconomy Biconomy +14.37%
#10 Audiera Audiera +14.30%
Coin of the day
MowCat MowCat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Integrated BioPharma, Inc. Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

INBP
Rang in aandelen #34627
Integrated BioPharma, Inc., together with its subsidiaries, engages in the... Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Aandeelprijs
$0.16795
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$5.22M
Verandering (1 dag)
4.97%
Verandering (1 jaar)
-37.80%
Land
US
Handel Integrated BioPharma, Inc. (INBP)

Categorie

Healthcare
Winst voor Integrated BioPharma, Inc. (INBP)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Integrated BioPharma, Inc. bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Integrated BioPharma, Inc. van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US